Representation-driven Endoscopic Visual Embedding Alignment for Latent Generation

Developing foundation generative models for endoscopy is limited by the gap between natural and clinical images and the computational cost of training large Diffusion Transformers. Although representation alignment has improved efficiency in general computer vision, its role within the highly specialized endoscopic image space remains unclear. We introduce REVEAL (Representation-driven Endoscopic Visual Embedding Alignment), the largest generative foundation model for endoscopy to date, trained on GastroNet-5M (GN-5M), a multicenter dataset of 5 million endoscopic frames. Instead of depending on out-of-domain priors, REVEAL employs encoders pretrained directly on the endoscopic distribution to align diffusion latents with domain-specific visual features, preserving fine textures and intricate anatomical structures. Beyond image generation, REVEAL also serves as a powerful feature extractor; in multiple benchmarks, it delivers performance that is competitive with, and in several cases exceeds, endoscopic foundation models such as EndoViT and Endo-FM, specifically tuned for classification tasks, while demonstrating strong representation robustness under realistic imaging corruptions. REVEAL produces high-fidelity images and maintains robust structural coherence in latent-space edits such as inpainting and outpainting. This high-capacity backbone lowers the computational threshold for building specialized clinical tools, offering an open, versatile foundation for conditional synthesis, segmentation, and out-of-distribution detection in future intelligent gastroenterology systems.

Development and evaluation of CADe systems in low-prevalence setting: The RARE25 challenge for early detection of Barrett's neoplasia

Computer-aided detection (CADe) of early neoplasia in Barrett's esophagus is a low-prevalence surveillance problem in which clinically relevant findings are rare. Although many CADe systems report strong performance on balanced or enriched datasets, their behavior under realistic prevalence remains insufficiently characterized. The RARE25 challenge addresses this gap by introducing a large-scale, prevalence-aware benchmark for neoplasia detection. It includes a public training set and a hidden test set reflecting real-world incidence. Methods were evaluated using operating-point-specific metrics emphasizing high sensitivity and accounting for prevalence. Eleven teams from seven countries submitted approaches using diverse architectures, pretraining, ensembling, and calibration strategies. While several methods achieved strong discriminative performance, positive predictive values remained low, highlighting the difficulty of low-prevalence detection and the risk of overestimating clinical utility when prevalence is ignored. All methods relied on fully supervised classification despite the dominance of normal findings, indicating a lack of prevalence-agnostic approaches such as anomaly detection or one-class learning. By releasing a public dataset and a reproducible evaluation framework, RARE25 aims to support the development of CADe systems robust to prevalence shift and suitable for clinical surveillance workflows.